RVT-501

· Dermavant Sciences GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RVT-501, covering 2018-08-06 to 2018-08-06. Get the full timeline:

Most recent: Clinical Trial Update: Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis [Phase 2]